Skip to content
healthcare.dev

Cilostazol

NDC 62135-983, Cilostazol, tablet, from Chartwell RX, LLC.

Product NDC
62135-983
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077310
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-983 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILOSTAZOL50 mg/1

Pharmacologic classes

Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]

Package NDCNDC-11Package
62135-983-606213509836060 TABLET in 1 BOTTLE (62135-983-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/77e77eaf-5556-43ac-844e-c0e29f02fe07

Use it

Look up 62135-983 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-983 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-983. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.